Home/Filings/4/0001209191-23-006047
4//SEC Filing

Thornton Michael Milos 4

Accession 0001209191-23-006047

CIK 0001681682other

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 8:30 PM ET

Size

5.4 KB

Accession

0001209191-23-006047

Insider Transaction Report

Form 4
Period: 2023-01-30
Thornton Michael Milos
Chief Technology Officer
Transactions
  • Award

    Stock Options

    2023-01-30+68,06668,066 total
    Exercise: $4.02Exp: 2033-01-30Common Stock (68,066 underlying)
Footnotes (1)
  • [F1]This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024.

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeother

Related Parties

1
  • filerCIK 0001706297

Filing Metadata

Form type
4
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 8:30 PM ET
Size
5.4 KB